Glakolens
Italy, IT · 1 known investors
Glakolens develops a non-invasive biosensor platform embedded in a disposable contact lens to enable continuous 24-hour intraocular pressure monitoring for patients at risk of glaucoma and ocular hypertension. The platform comprises a passive sensor on a soft contact lens and a wearable electronic system that wirelessly collects data during clinic-based monitoring sessions.
Investors · 1
In the news
Frequently asked questions
- What does Glakolens do?
- Glakolens develops a non-invasive biosensor platform embedded in a disposable contact lens to enable continuous 24-hour intraocular pressure monitoring for patients at risk of glaucoma and ocular hypertension. The platform comprises a passive sensor on a soft contact lens and a wearable electronic system that wirelessly collects data during clinic-based monitoring sessions.
- Who are Glakolens's investors?
- Glakolens's investors include ACT Venture Partners.
- Where is Glakolens headquartered?
- Glakolens is headquartered in Italy, IT.